MedTrace Logo

The Influence of a Bupivacaine Digital Nerve Block Using Rev G.

NCT01750554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2015-04-10

No results posted yet for this study

Summary

The investigators are proposing to continue investigation to improve the accuracy of the SpHb (continuous hemoglobin monitoring device) by administering an intermediate acting digital nerve block in the finger connected to the SpHb, specifically bupivacaine 0.25% in patients undergoing spine surgery. Bupivacaine is FDA approved and in routine use.

Conditions

  • Patients Undergoing Spine Surgery

Interventions

OTHER

intermediate-acting digital nerve block

non-therapeutic Bupivacaine digital nerve block to assess effect on accuracy of diagnostic readings

Sponsors & Collaborators

Principal Investigators

  • Ronald D Miller, MD, MS · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01750554 on ClinicalTrials.gov